Concerns Grow Over HHS Budget Cuts Impacting Public Health

During a recent hearing led by Chairman Aderholt, Ranking Member Rosa DeLauro scrutinized the budget proposal for the Department of Health and Human Services (HHS) for the upcoming fiscal year. DeLauro commended Secretary Kennedy's initiatives to reduce microplastics in drinking water and his collaboration with the Environmental Protection Agency (EPA) to identify them as contaminants.

DeLauro expressed concern over the administration’s budget proposal, which suggests a $16.5 billion reduction in health agency funding—a significant 14 percent cut. She emphasized the potential negative impacts on public health infrastructure, particularly the services from the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Administration for Healthcare Research and Quality (AHRQ), which are critical for maintaining public health and insurance market stability.

Highlighting staffing issues at the Centers for Disease Control and Prevention (CDC) and inadequate SAMHSA communication, DeLauro criticized the termination of NIH research grants concerning racial and gender health disparities and vaccine research. She further noted concerns about leadership changes at the CDC, specifically regarding the vaccine advisory panel, and the consequent rise in measles cases in the U.S.

The hearing also addressed financial management challenges within HHS, such as grant distribution delays by the Office of Management and Budget (OMB), impacting essential state and community programs. DeLauro firmly opposed the proposed budget cuts, worrying about their repercussions on public health systems and regulatory compliance requirements. She assured continuous scrutiny of these issues throughout the fiscal period.